Insider Transactions in Q2 2025 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2025
|
Kelley Boucher Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,095
+40.16%
|
-
|
|
May 28
2025
|
Kelley Boucher Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,087
+50.0%
|
-
|
|
May 21
2025
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,780
+1.09%
|
$38,340
$3.76 P/Share
|
|
Apr 17
2025
|
Craig A Wheeler Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,483
+50.0%
|
-
|